Status:
UNKNOWN
Alternations of Intestinal Microbiota and Health Impact in CKD
Lead Sponsor:
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Conditions:
Chronic Kidney Disease
Eligibility:
All Genders
20+ years
Brief Summary
This study is aimed to evaluate the impact of dietary pattern, gut microbiota and their interactions on clinical outcomes among patient with CKD stage 3-5.
Eligibility Criteria
Inclusion
- Patients with CKD stage 3-5 defined as eGFR \<60 ml/min/1.73 m2 calculated with the use of the four-variable Modification of Diet in Renal Disease formula who have not yet on dialysis therapy.
Exclusion
- Patients with active cancer
- Patients with liver cirrhosis
- Patients have taken antibiotics within three months before screening for inclusion.
- Patients with a cardiac pacemaker or metallic implants,
- Patients are amputees
- Pregnant women
- Patients with inherited renal diseases
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
750 Patients enrolled
Trial Details
Trial ID
NCT03794401
Start Date
April 1 2019
End Date
June 30 2023
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Tzu Chi Hospital
New Taipei City, Taiwan